4.7 Article

Reduced apelin levels in lone atrial fibrillation

Journal

EUROPEAN HEART JOURNAL
Volume 27, Issue 2, Pages 222-226

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehi648

Keywords

atrial fibrillation; arrhythmia; peptides; diagnosis

Funding

  1. NHLBI NIH HHS [HL71632, R01 HL075431, HL075431] Funding Source: Medline
  2. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL071632, R01HL075431] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Aims Apelin is an endogenous peptide hormone that appears to have a physiological role in counter-regulation of the angiotensin and vasopressin systems. This peptide has been reported to be down-regulated in subjects with acute heart failure, but has not been studied in other cardiovascular conditions. We studied apelin levels in 73 subjects with lone atrial fibrillation (AF). Methods and results Study subjects had electrocardiographic evidence of paroxysmal or chronic AF and a structurally normal heart on echocardiography. Subjects were excluded if they had a history of coronary artery disease, rheumatic heart disease, cardiomyopathy, significant valvular disease, hyperthyroidism, or antecedent hypertension. Controls were recruited from a healthy outpatient population. Plasma apelin levels were determined using a commercially available immunoassay. Seventy-three subjects with lone AF and 73 healthy controls were enrolled and studied. Mean levels of apelin were significantly lower in subjects with lone AF when compared with controls (307 vs. 648 pg/mL, P < 0.00005). Conclusion Reduced apelin levels were observed in this homogenous population of lone AF subjects and may represent an underlying diathesis predisposing to this common arrhythmia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available